Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPEF.L Regulatory News (APEF)

  • There is currently no data for APEF

Interim Management Statement

8 Feb 2013 15:17

RNS Number : 5205X
Aberdeen Private Equity Fund Ltd
08 February 2013
 



8 February 2013

Aberdeen Private Equity Fund Limited

Unaudited Interim Management Statement - three months to 31 December 2012

To the shareholders of Aberdeen Private Equity Fund Limited

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

This interim management statement relates to the period from 1 October to 31 December 2012, and contains information that covers this period and up to the publication date for this interim management statement, unless otherwise specified.

Overview

Aberdeen Private Equity Fund Limited ("the Company") is a Guernsey closed-ended investment company listed on the London Stock Exchange. The principal investment focus of the Company is to invest in private equity funds.

Investment Objective and Policy

The investment objective of the Company is to generate long-term capital gains, through investment in a diversified portfolio of private equity funds. The Company may also hold direct holdings as an ancillary part of its portfolio, in hedge funds, other speciality funds, unquoted companies and unquoted securities, including fixed-interest securities, cash-equivalent investments and cash.

Material Events

On 27 November 2012, the Company released its unaudited Half Yearly results for the period ended 30 September 2012.

Panmure Gordon (UK) Limited was appointed as broker for the Company with effect from 29 November 2012.

The Company currently has 109,131,199 Sterling shares in issue as at today's date.

Portfolio News

The Company's commitments total $256.3million, of which approximately $186.6million has been drawn down. There were twenty-eight capital calls made in the quarter with an aggregate amount of $4.9million. The Company received $10.2million in distributions in the quarter. The Company has received gross distributions, including return of excess capital called, of $96.2million since inception. Twenty-three revaluations were received during the quarter, fourteen of which were upwards revaluations and nine were downwards revaluations. Of the investments, 88% are calculated using currently available 30-Sept valuations, while the remaining 12% of investments are calculated using the last available valuations which are dated between 30-Sept and 31-Dec.

It is expected that Q4 valuations will start to come in from the middle of February. As such, 88% of the portfolio's private equity valuations are still based on 30-Sept figures. The marginal decline in the NAV in Dollar terms was as a result of calls on the Company to pay the fees of the underlying managers it invests in. A weakening of the Dollar against Sterling in December caused the NAV to decrease more materially in Sterling terms.

December was an eventful month, driven by the drama surrounding the US "fiscal cliff" negotiations which ended in a last minute deal that delayed automatic spending cuts and will result in $600bn more tax revenue over the next ten years.

As a result, there was a lot of corporate uncertainty in December, but despite this, the Company still received $5.3million of distributions. This included another distribution of $1.7million from Oaktree and also $1.3million from Thoma Bravo, who recalled and reinvested some of these proceeds into a new investment, Deltek, a US provider of enterprise software and information solutions for government contractors and professional services.

Goldman Sachs continued to monetise its portfolio, resulting in a $0.9million distribution in December. This came about as a result of various secondary offerings within the Fund's listed holdings, as well as a series of recapitalisations; an increasingly common theme in the portfolio, with Silver Lake and Thoma Bravo also following this route.

The other successful exit which resulted in a pay-out to the fund in December was the sale of Common Resources II by Pine Brook. This is a new North American shale gas company set-up by the management company of Common Resources I (following its sale), and the short holding period resulted in an IRR in excess of 50%.

Another event that took place in December was the acquisition by Nielsen, a global marketing analytics company held by Thomas H. Lee and a top 20 underlying holding, of Arbitron in an all cash transaction. The deal will give Nielsen access to a large source of data on US radio listeners helping the firm to cover a more comprehensive range of media consumption avenues.

With a total commitment cover of 59.5%, the Manager continues to look for new investment opportunities.

Portfolio Holdings as at 31 December 2012

%

Tenaya Capital V LP

6.6

Thomas H Lee Parallel Fund VI LP

6.4

Greenpark International Investors III LP

5.9

Thoma Bravo IX Fund LP

5.5

Silver Lake Partners III LP

5.1

DFJ Athena LP

5.0

Coller International Partners V LP

5.0

Northzone VI LP

4.9

RHO Ventures VI LP

4.8

Longreach Capital Partners Ireland 1, L.P.

4.3

HIG Bayside Debt & LBO Fund II LP

4.2

SVG Strategic Recovery Fund II LP

4.0

Goldman Sachs Capital Partners VI LP

4.0

Pine Brook Capital Partners LP

3.7

MatlinPatterson Global Opportunities Partners III LP

3.4

Lion Capital III LP

3.3

Oaktree OCM Opportunities Fund VIIb LP

3.1

Resonant Music LP

2.7

Gores Capital Partners III LP

2.2

Co-Investments

0.6

Pinebridge Latin America Partners II LP

0.6

Pangaea Two Parallel L.P.

0.5

Tenaya Capital VI LP

0.2

Deephaven Global Multi-Strategy Fund

0.0

Longreach Capital Partners 2 - USD, L.P.

-

Cash

14.0

 

Total

 

100.0

 

Total Number of Investments

 

25

 

Cash: The Company currently invests its cash with counterparties that appear on Aberdeen Asset Managers Limited's approved lending list.

 

Geographical Allocation as of 31 December 2012

%

Global

39.1

North America

35.1

Europe

14.2

Asia & Other

11.6

 

Total

 

100.0

 

General Description of Company's Financial Position as at 31 December 2012

Sterling Share NAV: 102.39 pence

Market Capitalisation: £75.8 million

As described in the Company's prospectus and as has been the case since its launch, the net asset value ("NAV") and the NAV per share are both calculated monthly by the Company's administrator based on the latest published NAV for each underlying fund.

Investments in underlying funds for the month ended 31 December 2012 are valued using the values (whether final or estimated) as advised by their managers, general partners or administrators. The Company therefore relied on valuation and reporting methods used by the managers, general partners or administrators of the underlying funds in deriving the 31 December 2012 NAV and NAV per share. It is possible, from time to time, that if there is good cause to reduce the underlying manager's valuation the Company will do so accordingly.

Benchmark

The Company does not currently have a benchmark. Due to the nature of the Company's investments, there are no meaningful indices against which to compare the performance of the Company.

Performance (%) (GBP)

Cumulative Performance

 

As at

31/12/2012

1 month

3 months

6 months

1 year

3 years

5 years

Share Price

69.5p

2.2

6.1

21.9

37.1

37.7

(22.6)

NAV

102.4p

(0.9)

(0.5)

(1.0)

5.6

26.7

5.0

 

Discrete Performance

 

Year Ended:

31/12/12

31/12/11

31/12/10

31/12/09

31/12/08

Share Price

37.1

(25.4)

34.6

18.9

(52.7)

NAV

5.6

11.2

7.9

(17.5)

0.4

 

Total Return; NAV to NAV, Net Income Reinvested, GBP.

Source: Aberdeen Asset Managers Limited and Morningstar.

NAV returns based on NAVs excluding income and with debt-valued at par.

On 19 November 2009 the management of the Company was assumed by Aberdeen Asset Managers Limited.

The Board is not aware of any other significant events or transactions which have occurred between 1 January 2013 and the publication date of this interim management statement which would have a material impact on the financial position of the Company.

For latest performance information, please refer to the Company's factsheet at:

http://www.aberdeenprivateequity.co.uk/doc.nsf/Lit/FactsheetUKClosedAberdeenPrivateEquityFund*

* Neither the content of the Company's website nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

Please note that past performance is not necessarily a guide to the future and that the value of investments and the income from them may fall as well as rise. Investors may not get back the amount they originally invested.

 

For Aberdeen Private Equity Fund Limited

Ipes (Guernsey) Limited

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGUAGPUPWGAR
Date   Source Headline
15th Sep 20172:00 pmRNSResult of AGM
1st Sep 20173:54 pmRNSPortfolio Listing, July 2017
30th Aug 20171:24 pmRNSNet Asset Value, July 2017
27th Jul 20174:29 pmRNSPortfolio Listing, June 2017
26th Jul 201711:56 amRNSNet Asset Value, June 2017
12th Jul 20177:00 amRNSPosting of Annual Report and AGM Notice
7th Jul 20173:45 pmRNSPortfolio Listing, May 2017
4th Jul 20173:28 pmRNSNet Asset Value, May 2017
26th Jun 20174:05 pmRNSAnnual Financial Report
26th Jun 201711:21 amRNSPortfolio Listing, April 2017
23rd Jun 201710:01 amRNSHolding(s) in Company
23rd Jun 20179:50 amRNSHolding(s) in Company
21st Jun 20174:35 pmRNSHolding(s) in Company
14th Jun 20172:00 pmRNSNet Asset Value, April 2017
12th Jun 20173:54 pmRNSHolding(s) in Company
19th May 20174:59 pmRNSCompliance with Market Abuse Regulations
10th May 201712:11 pmRNSPortfolio Listing, March 2017
5th May 20171:57 pmRNSNet Asset Value, March 2017
26th Apr 20172:11 pmRNSHolding(s) in Company
25th Apr 20174:01 pmRNSHolding(s) in Company
21st Apr 20173:19 pmRNSHolding(s) in Company
21st Apr 20171:23 pmRNSHolding(s) in Company
3rd Apr 20175:01 pmRNSPortfolio Listing, February 2017
30th Mar 20177:00 amRNSNet Asset Value, February 2017
21st Mar 20179:51 amRNSDirector/PDMR Shareholding
15th Mar 20171:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20179:19 amRNSPortfolio Listing, January 2017
27th Feb 20179:25 amRNSNet Asset Value, January 2017
1st Feb 20174:25 pmRNSPortfolio Listing, December 2016
27th Jan 20177:00 amRNSNet Asset Value(s)
23rd Dec 201612:00 pmRNSPortfolio Listing, November 2016
23rd Dec 201610:29 amRNSNet Asset Value, November 2016
20th Dec 20162:15 pmRNSPosting of Half Year Report
12th Dec 20164:55 pmRNSDividend Declaration - Correction
9th Dec 20167:05 amRNSAppointment of Broker
9th Dec 20167:00 amRNSHalf-year Report
2nd Dec 20163:47 pmRNSPortfolio Update
1st Dec 201612:35 pmRNSNet Asset Value, October 2016
4th Nov 20165:08 pmRNSProhibited Period Announcement
25th Oct 20164:07 pmRNSPortfolio Listing, September 2016
25th Oct 201611:37 amRNSDirector Declaration
25th Oct 201611:32 amRNSNet Asset Value, September 2016
4th Oct 20163:32 pmRNSPortfolio Listing, August 2016
3rd Oct 20163:57 pmRNSNet Asset Value - August 2016
21st Sep 20162:11 pmRNSDirector/PDMR Shareholding
13th Sep 201611:52 amRNSResult of AGM
25th Aug 20163:29 pmRNSPortfolio Listing, July 2016
24th Aug 20169:51 amRNSNet Asset Value(s)
28th Jul 201610:48 amRNSPortfolio Listing, June 2016
28th Jul 20167:00 amRNSNet Asset Value, June 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.